Azole antifungal

8 marketed 5 in Phase 3 4 in Phase 2 2 in Phase 1

This page covers all Azole antifungal drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fungal cytochrome P450 (lanosterol 14α-demethylase), Lanosterol 14α-demethylase (CYP51), Squalene epoxidase (fungal).

Targets

Fungal cytochrome P450 (lanosterol 14α-demethylase) · Lanosterol 14α-demethylase (CYP51) · Squalene epoxidase (fungal) · Thromboxane-A synthase · ATP-binding cassette sub-family G member 2 · Cytochrome P450 2C19 · Lanosterol 14α-demethylase · Fungal lanosterol 14α-demethylase (CYP51) · Fungal CYP51 (lanosterol 14α-demethylase) · 14-alpha-demethylase

Marketed (8)

Phase 3 pipeline (5)

Phase 2 pipeline (4)

Phase 1 pipeline (2)